ceRNA Network Analysis Shows That lncRNA CRNDE Promotes Progression of Glioblastoma Through Sponge mir-9-5p

Glioblastoma accounts for 45.2% of central nervous system tumors. Despite the availability of multiple treatments (e.g., surgery, radiotherapy, chemotherapy, biological therapy, immunotherapy, and electric field therapy), glioblastoma has a poor prognosis, with a 5-year survival rate of approximatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiaobin, Tu, Tianqi, Zhong, Yali, Xu, Shangyi, Chen, Xiangzhou, Chen, Ligang, Yang, Fubing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985093/
https://www.ncbi.nlm.nih.gov/pubmed/33767729
http://dx.doi.org/10.3389/fgene.2021.617350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985093/
https://www.ncbi.nlm.nih.gov/pubmed/33767729
http://dx.doi.org/10.3389/fgene.2021.617350

Ejemplares similares